Author Correction: Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation

Author Correction: Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation

Saved in:

Bibliographic Details
Main Authors:	Lin-Lin Kang, Dong-Mei Zhang, Chun-Hua Ma, Jian-Hua Zhang, Ke-Ke Jia, Jia-Hui Liu, Rong Wang, Ling-Dong Kong
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-11-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-024-81009-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation
by: Lin-Lin Kang, et al.
Published: (2016-06-01)

Hydrogen-Rich Saline Inhibits NLRP3 Inflammasome Activation and Attenuates Experimental Acute Pancreatitis in Mice
by: Jian-Dong Ren, et al.
Published: (2014-01-01)

Irisin Attenuates Neuroinflammation Targeting the NLRP3 Inflammasome
by: Francesca Martina Filannino, et al.
Published: (2024-11-01)

Carvacrol alleviates LPS-induced myocardial dysfunction by inhibiting the TLR4/MyD88/NF-κB and NLRP3 inflammasome in cardiomyocytes
by: Lu Xu, et al.
Published: (2024-11-01)

TBK1 and Caspase-8 suppress necroptosis but activate NLRP3 inflammasome activation during CXCL4 and TLR8 costimulation
by: Ying Cui, et al.
Published: (2024-12-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

Function of NLRP3 inflammasome activation in multiple myeloma
by: Xiaorong Zhu, et al.
Published: (2024-12-01)

CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy
by: Jing Zhao, et al.
Published: (2019-01-01)

Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”
by: Jing Zhao, et al.
Published: (2019-01-01)

Inhibition of the NLRP3 inflammasome attenuates spiral ganglion neuron degeneration in aminoglycoside-induced hearing loss
by: Jia Fang, et al.
Published: (2025-10-01)

Berberine Mitigates Sepsis-Associated Acute Kidney Injury in Aged Rats by Preserving Mitochondrial Integrity and Inhibiting TLR4/NF-κB and NLRP3 Inflammasome Activations
by: Ruedeemars Yubolphan, et al.
Published: (2024-11-01)

Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
by: Jun Chen, et al.
Published: (2025-01-01)

NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation
by: Agata Habas, et al.
Published: (2022-01-01)

Artesunate: attenuating TLR4/MD2 signaling to alleviate cardiac fibrosis
by: Lars Koch, et al.
Published: (2025-01-01)

Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis
by: Yingnan Hu, et al.
Published: (2025-01-01)

Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
by: Yi Huang, et al.
Published: (2018-03-01)

Betaine Inhibits NLRP3 Inflammasome Hyperactivation and Regulates Microglial M1/M2 Phenotypic Differentiation, Thereby Attenuating Lipopolysaccharide-Induced Depression-Like Behavior
by: Man Zhang, et al.
Published: (2022-01-01)

Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model
by: Wei Meng, et al.
Published: (2023-12-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
by: Mohsin H. K. Roshan, et al.
Published: (2016-01-01)

Zhili decoction ameliorates ulcerative colitis by modulating gut microbiota and related metabolite, and inhibiting the TLR4/NF-κB/NLRP3 pathway
by: Tianying Tan, et al.
Published: (2024-12-01)

Mechanism of activation of TLR4/NF-κB/NLRP3 signaling pathway induced by heat stress disrupting the filtration barrier in broiler
by: Hui-li Dong, et al.
Published: (2024-12-01)

Verbascoside Inhibits the Activation of NLRP3 Inflammasome and Improves BV-2 Cell Inflammatory Damage
by: Wenjing HUANG, et al.
Published: (2025-02-01)

Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation
by: Yaoyao Xu, et al.
Published: (2024-12-01)

NLRP3 Inflammasome Activation Is Involved in Geniposide-Induced Hepatotoxicity
by: Yixuan Liu, et al.
Published: (2025-01-01)

Commentary: BAFF blockade attenuates DSS-induced chronic colitis via inhibiting NLRP3 inflammasome and NF-кB activation
by: Jie Guo, et al.
Published: (2024-12-01)

Particulate Matter Induces NLRP3 Inflammasome-Mediated Pyroptosis in Human Nasal Epithelial Cells
by: Hosung Choi, et al.
Published: (2024-07-01)

ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation
by: Yuan Chang, et al.
Published: (2025-01-01)

TLR4 Inhibition Attenuated LPS‐Induced Proinflammatory Signaling and Cytokine Release in Mouse Hearts and Cardiomyocytes
by: Christine W. Wiger, et al.
Published: (2025-01-01)

TLR4/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis
by: Xiang Hu, et al.
Published: (2020-01-01)

NLRP3 Inflammasome Upregulates PD-L1 in Ovarian Cancer and Contributes to an Immunosuppressive Microenvironment
by: Pan W, et al.
Published: (2024-12-01)

Inflammasome-targeted therapy for oral cancer: Highlighting NLRP3 inflammasome as a promising clinical therapeutic target
by: Geetha Shanmugam
Published: (2024-06-01)

The microneme protein1 (MIC1) of Chinese 1 Toxoplasma regulates pyroptosis through the TLR4/NLRP3 pathway in macrophages
by: Wenze Sun, et al.
Published: (2024-11-01)

Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
by: Ping Li, et al.
Published: (2025-01-01)

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01)

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration
by: Jiangyuan Gao, et al.
Published: (2015-01-01)

The role of NLRP3 inflammasome in type 2 inflammation related diseases
by: Shenming Xu, et al.
Published: (2024-12-01)

ROS-Mediated NLRP3 Inflammasome Activity Is Essential for Burn-Induced Acute Lung Injury
by: Shichao Han, et al.
Published: (2015-01-01)

CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
by: YaoMing Zheng, et al.
Published: (2025-01-01)